Leugard 22.5mg Depot Injection

Leugard 22.5mg Depot Injection is a prescription hormonal medicine that contains leuprorelin 22.5mg. It belongs to a group of medicines called gonadotropin-releasing hormone (GnRH) agonists. Doctors use this medicine to manage certain hormone-sensitive conditions.

Leugard 22.5mg works by changing the production of sex hormones in the body. Depending on the condition being treated, this action can reduce testosterone or oestrogen activity and help control hormone-dependent disease processes.

Current Indian medicine listings describe Leugard 22.5mg Depot Injection as a prescription injection manufactured or marketed by Zydus Cadila. It is administered by a qualified healthcare professional rather than being self-injected by the patient. :contentReference[oaicite:3]{index=3}

Composition of Leugard 22.5mg Injection

The active ingredient in Leugard 22.5mg Depot Injection is:

• Leuprorelin: 22.5mg

Leuprorelin is a synthetic analogue of gonadotropin-releasing hormone. The depot formulation releases the medicine over an extended period according to the characteristics of the specific product.

What is Leugard 22.5mg Injection Used For?

Doctors may prescribe Leugard 22.5mg Depot Injection for hormone-sensitive conditions such as:

• Advanced or hormone-sensitive prostate cancer
• Endometriosis
• Uterine fibroids
• Central precocious puberty in selected children

The approved uses can vary according to the specific leuprorelin formulation and local prescribing information. Therefore, the treating doctor should determine whether Leugard is appropriate for a particular patient. Current Indian product listings include these conditions among its uses. :contentReference[oaicite:4]{index=4}

Leugard 22.5mg for Prostate Cancer

Leugard may be used as part of hormone therapy for advanced or hormone-sensitive prostate cancer. Prostate cancer cells can respond to male sex hormones, particularly testosterone. By reducing hormone stimulation, leuprorelin can help slow the growth of hormone-sensitive cancer.

Leugard is not a conventional chemotherapy medicine. It is a hormonal treatment that works through the GnRH pathway.

Leugard 22.5mg for Endometriosis

Doctors may use leuprorelin to reduce ovarian hormone stimulation in patients with endometriosis. Lower oestrogen activity can temporarily reduce the stimulation of endometrial-like tissue and may help control symptoms such as pelvic pain.

Treatment duration for endometriosis should follow the specialist’s instructions because prolonged suppression of oestrogen can affect bone mineral density.

Leugard 22.5mg for Uterine Fibroids

Leuprorelin can reduce ovarian hormone activity and may temporarily shrink uterine fibroids. Doctors may use hormonal therapy in selected patients to control symptoms such as heavy menstrual bleeding or to prepare for certain procedures.

Leugard 22.5mg for Early Puberty

In selected children with central precocious puberty, GnRH agonist treatment can temporarily suppress the hormone signals responsible for early sexual development. This treatment should be supervised by an appropriate paediatric specialist.

How Does Leugard 22.5mg Injection Work?

Leugard contains leuprorelin, a GnRH agonist. At the beginning of treatment, GnRH agonists can temporarily increase certain reproductive hormone levels. With continuous exposure, however, the pituitary gland becomes less responsive to the GnRH signal.

This eventually reduces the production of sex hormones. In men, testosterone levels fall significantly. In women, ovarian hormone activity can decrease. The resulting hormone suppression helps manage hormone-dependent conditions.

Benefits of Leugard 22.5mg Injection

Helps Control Hormone-Sensitive Prostate Cancer

By reducing testosterone stimulation, leuprorelin can help slow the growth of hormone-sensitive prostate cancer and form part of a long-term androgen-deprivation treatment plan.

Helps Manage Endometriosis

Reduced oestrogen activity may decrease hormonal stimulation of endometriosis tissue and help control related symptoms.

May Reduce Uterine Fibroid Size

Leuprorelin can temporarily reduce hormonal stimulation of uterine fibroids and may help control heavy menstrual bleeding in selected patients.

Helps Suppress Early Puberty

In children with central precocious puberty, GnRH agonist treatment can temporarily suppress premature sex hormone production.

How Leugard 22.5mg Injection Is Given

Leugard 22.5mg Depot Injection must be administered by a qualified healthcare professional.

• Do not self-inject this medicine.
• The healthcare professional prepares the depot formulation according to the product instructions.
• The injection route depends on the specific formulation.
• The doctor determines the injection interval according to the medical condition.
• Attend all scheduled appointments to maintain the treatment schedule.

For 22.5mg leuprolide depot formulations, a three-month dosing interval is used for some indications and products. However, patients should follow the exact schedule prescribed for their Leugard product. :contentReference[oaicite:5]{index=5}

Leugard 22.5mg Dosage

The correct dosage depends on the condition being treated, the patient’s age, medical history and the particular depot formulation.

Do not decide the injection frequency yourself. The doctor will select the appropriate dose and interval. A 22.5mg depot formulation may provide extended hormone suppression over several weeks or months.

Missed Injection

If you miss your scheduled Leugard injection appointment, contact your doctor or treatment centre as soon as possible. Do not attempt to compensate for a missed injection yourself.

Leugard 22.5mg Injection Side Effects

Leugard can cause side effects because it changes sex hormone levels in the body. The type and severity of side effects can vary between patients and can also depend on the condition being treated.

Common Side Effects

• Hot flashes
• Increased sweating
• Fatigue
• Headache
• Muscle weakness
• Bone or joint discomfort
• Reduced sexual desire
• Erectile difficulties in men
• Mood changes
• Injection-site pain, redness or swelling

Current Indian product information also reports hormonal and injection-site effects among possible adverse reactions. :contentReference[oaicite:6]{index=6}

Long-Term Effects on Bone Health

Long-term suppression of sex hormones can reduce bone mineral density in some patients. This risk is particularly important when treatment continues for a prolonged period.

Your doctor may consider bone-health monitoring and may advise adequate calcium, vitamin D and suitable physical activity when appropriate.

Serious Side Effects and When to Seek Medical Help

Contact your doctor promptly if you develop severe or unusual symptoms during treatment.

• Severe allergic reaction
• Severe chest pain or breathing difficulty
• Fainting or severe weakness
• New or worsening neurological symptoms
• Severe mood changes
• Unusual heart rhythm or palpitations
• Severe bone pain or symptoms suggesting a fracture

Precautions for Leugard 22.5mg Injection

• Use Leugard only under medical supervision.
• Tell your doctor if you have heart disease.
• Tell your doctor if you have a history of osteoporosis or low bone density.
• Inform your doctor if you have diabetes.
• Tell your doctor if you have a history of depression or significant mood problems.
• Inform your doctor about all medicines and supplements you take.
• Tell your doctor if you have had previous hormone-related treatment.
• Discuss pregnancy plans with your doctor before treatment.

Leugard 22.5mg and Pregnancy

Leugard should not be used during pregnancy unless specifically directed under an appropriate specialist treatment plan. Leuprorelin changes reproductive hormone activity and can affect pregnancy.

Women who may become pregnant should discuss appropriate contraception with their healthcare professional. Inform your doctor immediately if you become pregnant during treatment.

Leugard 22.5mg and Breastfeeding

Leugard is generally not recommended during breastfeeding. Tell your doctor if you are breastfeeding before receiving the injection so that the healthcare professional can assess the appropriate treatment plan.

Leugard 22.5mg and Diabetes

Hormonal changes caused by GnRH agonists can affect blood glucose control in some patients. People with diabetes may therefore need closer monitoring of blood sugar during treatment.

Tell your doctor if you have diabetes before starting Leugard therapy.

Leugard 22.5mg and Bone Health

Because prolonged reduction of sex hormones can affect bone density, patients receiving long-term treatment may need medical assessment of bone health.

A balanced diet, adequate calcium and vitamin D intake, and suitable weight-bearing activity may support bone health. However, do not start supplements without discussing them with your doctor.

Leugard 22.5mg and Heart Health

Tell your doctor if you have a history of heart disease, abnormal heart rhythm or other cardiovascular problems. Your doctor may decide whether additional monitoring is necessary during treatment.

Leugard 22.5mg Drug Interactions

Tell your doctor about every medicine you use before receiving Leugard. This includes prescription medicines, over-the-counter products, vitamins and herbal supplements.

Particular attention may be needed with medicines that affect heart rhythm, blood glucose or other conditions that can be influenced by hormone therapy.

Leugard 22.5mg and Driving

Some patients may experience dizziness, fatigue or visual disturbances. If you experience these symptoms, avoid driving or operating machinery until you feel alert and safe.

Storage of Leugard 22.5mg Injection

• Store the product according to the instructions on the original package.
• Current Indian listings specify refrigerated storage at 2°C to 8°C.
• Do not freeze.
• Protect the medicine from inappropriate heat and direct exposure.
• Keep the product out of reach of children.
• Do not use the product after its expiry date.

Storage requirements can depend on the exact marketed formulation and pack. Always follow the storage instructions printed on your Leugard package. :contentReference[oaicite:7]{index=7}

Important Safety Information

Leugard 22.5mg Injection is a prescription hormonal medicine. It should only be administered by a trained healthcare professional.

Do not change the injection schedule, discontinue treatment or receive another hormonal medicine without consulting your doctor.

Frequently Asked Questions About Leugard 22.5mg Injection

1. What is Leugard 22.5mg Injection?

Leugard 22.5mg Depot Injection is a prescription hormonal medicine containing leuprorelin 22.5mg. It belongs to the GnRH agonist group.

2. What is Leugard 22.5mg used for?

Current Indian product information lists its use for conditions such as prostate cancer, endometriosis, uterine fibroids and central precocious puberty. The exact approved use depends on the specific formulation and clinical situation.

3. What is the composition of Leugard 22.5mg?

Leugard 22.5mg contains leuprorelin 22.5mg.

4. Is Leugard 22.5mg a chemotherapy medicine?

No. Leugard is a hormonal medicine and belongs to the GnRH agonist class. It works by suppressing sex hormone production rather than directly acting as conventional chemotherapy.

5. How does Leugard work?

Continuous GnRH agonist treatment reduces pituitary signalling and eventually lowers sex hormone production. In men, this substantially reduces testosterone levels.

Key Facts About Leugard 22.5mg Injection

Important Usage Tips

• Use Leugard only on a doctor’s prescription.
• Do not self-administer the injection.
• Attend every scheduled injection appointment.
• Tell your doctor about diabetes or heart disease.
• Inform your doctor about osteoporosis or low bone density.
• Report severe or unusual symptoms promptly.
• Discuss pregnancy prevention with your healthcare professional.
• Follow the recommended storage conditions.
• Do not change the treatment schedule without medical advice.

Internal Links

• Online Generic Med Home
• Healthcare Blog
• Online Medicine Shop

External Medical Resources

• DailyMed: Leuprolide Depot Prescribing Information
• EMC: Leuprorelin 22.5mg SmPC

Conclusion

Leugard 22.5mg Depot Injection contains leuprorelin, a GnRH agonist used to manage certain hormone-sensitive conditions. Current Indian product information lists uses including prostate cancer, endometriosis, uterine fibroids and central precocious puberty. :contentReference[oaicite:9]{index=9}

The medicine works by reducing sex hormone production after continuous GnRH stimulation. Because it produces significant hormonal changes, treatment requires medical supervision and regular follow-up.

Patients should follow the prescribed injection schedule and report symptoms such as severe mood changes, significant weakness, unusual heart symptoms or other serious reactions. Long-term treatment may also require attention to bone health.